BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model - (:unkn) unknown (My University, 2020)
Keywords: Female; Humans; Biomarkers; Proto-Oncogene Proteins B-raf; Mutation; Cell Line, Tumor; Breast Neoplasms; MCF-7 Cells; breast cancer; Trastuzumab; Class I Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins p21(ras); PIK3CA; Cell line